Allergy & Immunology

Researchers developed a new evolutionary framework centred on immune robustness, the ability to fight infection while limiting damage.

A recent randomised clinical trial sought to determine whether high-dose aspirin remains necessary during acute-stage KD treatment.

The RILECSU phase 2 clinical trial has introduced a potential new option: rilzabrutinib.

During the immunosuppressive phase, researchers identified a marked decline in monocyte function and maturation.

Researchers have discovered a myeloid-derived APC population that is essential for generating both food- and microbiota-specific peripherally induced regulatory T cells.

The study suggests that initiating Artemisia annua SLIT during the pollen season is just as safe and well-tolerated as starting it before.

The results suggest that Wendan Decoction and acupuncture into treatment plans may enhance clinical outcomes for patients with urticaria.

A recent single-blind, randomised controlled trial evaluated the efficacy of normal saline nasal irrigation in managing allergic rhinitis symptoms.